Surgepays Historical Income Statement
| SURG Stock | USD 1.92 0.19 9.00% |
Historical analysis of Surgepays income statement accounts such as Operating Income of 19.8 M, Ebit of 19.9 M, EBITDA of 21.1 M or Total Operating Expenses of 17.6 M can show how well Surgepays performed in making a profits. Evaluating Surgepays income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Surgepays's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Surgepays latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Surgepays is a good buy for the upcoming year.
Surgepays |
About Surgepays Income Statement Analysis
Surgepays Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Surgepays shareholders. The income statement also shows Surgepays investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Surgepays Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Surgepays. It is also known as Surgepays overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Surgepays' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Surgepays current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.At this time, Surgepays' Selling General Administrative is most likely to increase significantly in the upcoming years. The Surgepays' current Other Operating Expenses is estimated to increase to about 124.2 M, while Income Tax Expense is forecasted to increase to (2.2 M).
| 2023 | 2024 (projected) | Interest Income | 1.3M | 1.1M | Reconciled Depreciation | 1.1M | 740.0K |
Surgepays income statement Correlations
Click cells to compare fundamentals
Surgepays Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Surgepays income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | (173.1K) | 1.4M | 917.5K | 988.7K | 1.1M | 1.2M | |
| Interest Expense | 227.0K | 3.4M | 7.5M | 2.0M | 596.0K | 1.1M | |
| Selling General Administrative | 10.9M | 9.4M | 10.7M | 11.7M | 15.6M | 16.3M | |
| Other Operating Expenses | 32.5M | 62.8M | 57.0M | 120.9M | 118.3M | 124.2M | |
| Operating Income | (6.8M) | (8.4M) | (6.0M) | 873.7K | 18.9M | 19.8M | |
| Ebit | (6.8M) | (6.8M) | (6.2M) | 873.7K | 19.0M | 19.9M | |
| Ebitda | (7.0M) | (5.4M) | (5.2M) | 1.9M | 20.1M | 21.1M | |
| Total Operating Expenses | 12.2M | 10.9M | 12.2M | 12.8M | 16.8M | 17.6M | |
| Income Before Tax | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 18.4M | 19.3M | |
| Total Other Income Expense Net | (1.7M) | (576.0K) | (7.5M) | (1.2M) | (485.8K) | (510.1K) | |
| Net Income | (8.2M) | (16.9M) | (18.8M) | (148.9K) | 20.6M | 21.6M | |
| Income Tax Expense | (229.0K) | 6.2M | 5.3M | (404.4K) | (2.3M) | (2.2M) | |
| Total Revenue | 25.7M | 54.4M | 51.1M | 121.5M | 137.1M | 144.0M | |
| Gross Profit | 5.4M | 2.5M | 6.2M | 13.5M | 35.6M | 37.4M | |
| Cost Of Revenue | 20.3M | 51.9M | 44.9M | 108.1M | 101.5M | 106.6M | |
| Selling And Marketing Expenses | 1.1M | 273.0K | 661.2K | 259.4K | 152.9K | 145.2K | |
| Net Income From Continuing Ops | (8.4M) | (10.7M) | (13.5M) | (553.2K) | 20.6M | 21.7M | |
| Net Income Applicable To Common Shares | (8.4M) | (10.7M) | (13.5M) | (680.8K) | (612.7K) | (643.3K) | |
| Net Interest Income | (227.0K) | (3.4M) | (7.5M) | (2.0M) | (596.0K) | (625.8K) | |
| Reconciled Depreciation | 55.6K | 1.4M | 917.5K | 988.7K | 1.1M | 740.0K |
Currently Active Assets on Macroaxis
When determining whether Surgepays is a strong investment it is important to analyze Surgepays' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Surgepays' future performance. For an informed investment choice regarding Surgepays Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surgepays. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more detail on how to invest in Surgepays Stock please use our How to Invest in Surgepays guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Wireless Telecommunication Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surgepays. If investors know Surgepays will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surgepays listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share (1.18) | Revenue Per Share 6.864 | Quarterly Revenue Growth (0.58) | Return On Assets (0.02) |
The market value of Surgepays is measured differently than its book value, which is the value of Surgepays that is recorded on the company's balance sheet. Investors also form their own opinion of Surgepays' value that differs from its market value or its book value, called intrinsic value, which is Surgepays' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surgepays' market value can be influenced by many factors that don't directly affect Surgepays' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surgepays' value and its price as these two are different measures arrived at by different means. Investors typically determine if Surgepays is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surgepays' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.